本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

198.35
-6.5100-3.18%
成交量:106.44萬
成交額:2.13億
市值:425.14億
市盈率:-22.23
高:205.15
開:205.13
低:197.80
收:204.86
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:1.43
換手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.31
市盈率(LYR):-33.34

資料載入中...

2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

SEC問詢函

Form CORRESP - Correspondence
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities